Atlas Trials

Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer

Clinical trial NCT04194125 · UNKNOWN

Trial details

NCT number
NCT04194125
Sponsor
University of Warmia and Mazury
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2019-02-01
Primary completion
2021-06-30
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.